2027 Future Talent Program - Global Regulatory Affairs & Compliance US Subsidiary - Intern

Job Description

2027 Future Talent Program - Global Regulatory Affairs & Compliance US Subsidiary - Intern Drug Shortages & Support Functions (DSSF) The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. These opportunities in our Research and Development Division can provide you with great development and a chance to see if we are the right company for your long-term goals This intern position is part of the Global Regulatory Affairs and Clinical Safety (GRACS) US Subsidiary function within our Company's Research Laboratories. This is an exciting time to join the US Subsidiary regulatory space, as we navigate evolving expectations and drive impactful change in our industry. The US Subsidiary team serves as a trusted regulatory center of excellence leading strategic interactions with the U.S. Food and Drug Administration (FDA) related to drug shortages and other regulatory support activities. The team partners with stakeholders across Regulatory Affairs, Manufacturing, Supply Chain, Quality, Medical Affairs, Communications, and Legal to help prevent, mitigate, and minimize the impact of supply disruptions on patients, while ensuring compliance with applicable regulatory requirements. The organization also supports regulatory intelligence activities, process improvement initiatives, FDA inquiries, and industry engagement to advance supply resiliency efforts. Flexibility and agility in responding to evolving business processes are crucial, as expectations continually change. As a Summer Intern, you will have the opportunity to gain hands-on experience in pharmaceutical regulatory affairs by supporting the Drug Shortages & Support Functions team and various company and industry-wide initiatives through cross-functional collaboration with internal and external stakeholders. The intern will contribute to projects focused on regulatory intelligence, regulatory strategy, and drug shortage prevention activities while